Effects of Group Physical Therapy on Walking Speed in Patients With Parkinson Disease
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Parkinson disease is a progressive neurologic disorder characterized by motor impairments which alter the walking capacity, and lead to reduced walking speed, decreased stride length and increased double support time. Physical therapy interventions are an important part of the non-pharmacological treatment for Parkinson disease. The purpose of this study was to assess whether there is a different outcome regarding improvement of walking speed, when applying a physical therapy program in an individual or in a group manner. A prospective, observational, cohort type study on 60 patients with Parkinson disease was carried out between November 2014 - July 2017, in the Clinical Rehabilitation Hospital in Cluj-Napoca, Cluj county, Romania. Patients were randomly divided into 2 groups, and were prescribed either individual (1 patient and 1 physical therapist) or group physical therapy (6 patients and 1 physical therapist). Treatment protocol included 10 sessions of physical therapy, in the same room setting and performed the same routine of exercises, except for the 3 breaks during the sessions in the group therapy for informal socialization. Walking speed was measured by two validated instruments, the 6-minute walk test and the 10-meter walk test, before and after treatment. Patients with PD could benefit more from a group physical therapy program, as gait speed increased significantly. The group approach facilitates interactions and is cost-effective, as it requires only one therapist and more patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Nov 2014
Typical duration for not_applicable parkinson-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 28, 2019
CompletedFirst Posted
Study publicly available on registry
December 5, 2019
CompletedDecember 5, 2019
December 1, 2019
2.7 years
November 28, 2019
December 3, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Walking speed (meters/seconds)
the 6-minute walking test
at baseline and after 10 days
Change in Walking speed
the 10-meter walking test.
at baseline and after 10 days
Study Arms (2)
Group physical therapy
EXPERIMENTALGroups of 6 patients and 1 physical therapist for the 1.5 hour physical therapy session
Individual physical therapy
ACTIVE COMPARATOR1.5 hour physical therapy session 1 on 1 (1 patient and 1 physical therapist)
Interventions
The rehabilitation protocol for the IPT consisted of cardiovascular warm-up activities, stretching exercises, strengthening exercises, functional, gait and balance training, recreational games and ended with relaxation exercises. In addition, the GPT protocol followed the exact same pattern, except for 5-10 minute breaks for informal socialization between participants, at the beginning of the session, mid-session and at the end of the session. Also, both groups had access to external cues, which were applied during a variety of tasks and environmental situations, like gait initiation and termination, heel strike and push-off, sideways and backwards stepping, walking while dual tasking, and walking over various surfaces and long distances.
Eligibility Criteria
You may qualify if:
- stable medication usage;
- Hoehn and Yahr stage 2, 3 or 4;
- ability to walk independently or by using an assistive walking device;
- age 50 to 70 years;
- no severe cognitive impairments (Mini-Mental State Examination - MMSE score, ≥24);
- no other severe neurologic, cardiopulmonary or orthopedic disorders;
- not having participated in a PT or rehabilitation program in the previous 2 months.
You may not qualify if:
- not stable medication usage;
- Hoehn and Yahr stage 1;
- inability to walk independently or by using an assistive walking device;
- age less than 50 and more than 70 years;
- severe cognitive impairments (Mini-Mental State Examination - MMSE score, below 24);
- other severe neurologic, cardiopulmonary or orthopedic disorders;
- having participated in a PT or rehabilitation program in the previous 2 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 28, 2019
First Posted
December 5, 2019
Study Start
November 1, 2014
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
December 5, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL